Copertina

Impact of Tenofovir Alafenamide on Lipid Profiles in Chronic Hepatitis B Patients: Systematic Review and Meta‐Analysis

Fuente: Wiley Open Access

Salvato in:

Dettagli Bibliografici
Autori principali:	Ping‐Yu Hsu, Hui‐Chen Su, Mi‐Chia Ma, Chien‐An Chen, Sin‐Yi Yu, Yi‐Ming Hua
Natura:	Artículo Open Access
Pubblicazione:	Wiley 2025
Soggetti:	Journal of Medical Virology
Accesso online:	Acceder al recurso
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!

Documenti analoghi

Atherosclerotic Cardiovascular Risk in Patients with Chronic Hepatitis B: Tenofovir Disoproxil Fumarate Vs. Tenofovir Alafenamide: A Korean Nationwide Study
di: Jiwon Yang, et al.
Pubblicazione: (2026)

Tenofovir Disoproxil Fumarate Versus Entecavir: Effects on Lipid Profiles and Cardiovascular Outcomes in People Living With Chronic Hepatitis B
di: Log Young Kim, et al.
Pubblicazione: (2025)

A Comparative Study of Entecavir and Tenofovir Alafenamide on Quantitative HBsAg Reduction in Patients With CHB
di: Jungnam Lee, et al.
Pubblicazione: (2026)

Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral Therapy
di: Sheng‐Jie Shiue, et al.
Pubblicazione: (2026)

Advances in Rapid Nucleic Acid Diagnostics for Hepatitis B and C Viruses: A Comprehensive Review
di: Hsin‐Ying Ho, et al.
Pubblicazione: (2026)

HBV Recurrence Detected by HBV‐Related Serum Markers and Immune Escape Mutations in Chronic Hepatitis B Patients Following Liver Transplantation
di: Chien‐Ming Chiang, et al.
Pubblicazione: (2025)

An Investigative Study of LGALSL and HLA‐DRB1 as Prognostic Biomarkers and Therapeutic Targets in Chronic Hepatitis B Patients With Persistent HBV DNA Viremia Under Entecavir Treatment
di: Qun Wan, et al.
Pubblicazione: (2025)

Autoantibody Profiles and Prognostic Significance in Severe Fever With Thrombocytopenia Syndrome (SFTS) Patients
di: Hongyan Hou, et al.
Pubblicazione: (2025)

Dynamics of Serum Hepatitis B Virus Nucleic Acids in Patients With Chronic Hepatitis B After Stopping Nucleos(t)ide Analogs Reveal Delayed Rebound of Hepatitis B Virus RNA
di: Wanying Li, et al.
Pubblicazione: (2025)

Seroprevalence of Viral Hepatitis B and Occult Hepatitis B Among Blood Donors in Africa: A Systematic Review and Meta‐Analysis
di: Abibou Simpore, et al.
Pubblicazione: (2024)

The Effectiveness of COVID‐19 Vaccination on Post‐Acute Sequelae of SARS‐CoV‐2 Infection Among Geriatric Patients
di: Yi‐Ju Chan, et al.
Pubblicazione: (2024)

Paternally Expressed Gene 10 Promoter Methylation Level as a Predictor of HBeAg Seroconversion in Chronic Hepatitis B Patients
di: Pengyu Luo, et al.
Pubblicazione: (2025)

Alcohol‐Induced Dendritic Cells and Their Exosomes Promote T‐Cell Immunity in Hepatitis B Virus Transgenic Mice and Patients With Chronic Hepatitis B
di: Xingzhong Miao, et al.
Pubblicazione: (2025)

Reduction of Bacteroides fragilis in Gut Microbiome of Chronic Hepatitis B Patients Promotes Liver Injury
di: Qiuhong You, et al.
Pubblicazione: (2025)

Intravenous fluid therapy in hospitalized adult dengue patients without shock: Impact on subsequent severe dengue and potential adverse effects
di: Baihui Xu, et al.
Pubblicazione: (2024)

Prognostic Value of Admission Glucose and Extended Lipid Profile in Patients with Crimean‐Congo Hemorrhagic Fever
di: Yasemin Çakır Kıymaz, et al.
Pubblicazione: (2026)

Risk Factors for Mortality in Patients With Novel Bunyavirus Infection: A Systematic Review and Meta‐Analysis
di: Shan Niu, et al.
Pubblicazione: (2026)

Obstructive Sleep Apnea and Risk of Respiratory Syncytial Viral Infection: A Retrospective Multi‐Institution Cohort Study
di: Sunny Ssu‐Yu Chen, et al.
Pubblicazione: (2025)

Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in Hepatitis B Patients on Long‐Term Antiviral Therapy: A Systematic Review and Meta‐Analysis
di: Jayakrishna Pamarthi, et al.
Pubblicazione: (2026)

Novel intertypic recombination of Echovirus 11 in the Enterovirus species B
di: Yu‐Nong Gong, et al.
Pubblicazione: (2024)

HBcrAg Dynamic Change During Treatment Predicts HBsAg Loss in Pediatric Patients With Chronic Hepatitis B
di: Ling Ye, et al.
Pubblicazione: (2025)

Epidemiological Profiles of Hepatitis B Virus Genotypes Among 1–69‐year‐olds in the Mainland of China
di: Qiudong Su, et al.
Pubblicazione: (2025)

Monkeypox Virus Is Inhibited by Nucleoside Analogues Including the Acyclic Phosphonates Adefovir and Tenofovir In Vitro
di: Jasper Lee, et al.
Pubblicazione: (2025)

New‐Onset Major Depressive Disorder, Schizophrenia and Bipolar Disorder in People With Human Papillomavirus Diagnosis: A Population‐Based Cohort Study
di: Hui‐Chin Chang, et al.
Pubblicazione: (2025)

Bacterial Co‐Infection Delays Hepatitis B Virus Clearance in a Chronic Replication Mouse Model by Inducing T Cell Exhaustion
di: Sumeng Li, et al.
Pubblicazione: (2025)

Suppression of Calcium Influx Reduces Coxsackievirus B3 Lethality With Elevated Interferon Beta Responses in Mice
di: Yi‐Ling Hsiao, et al.
Pubblicazione: (2026)

Associations of Lipid Profiles With the Onset of HEV‐Related Acute Liver Failure: A Multicenter Cohort Study
di: Rui Dong, et al.
Pubblicazione: (2024)

Hospitalised Dengue Patients and Risk of Hypertension: A Systematic Review and Meta‐Analysis
di: Tonggang Zhu, et al.
Pubblicazione: (2025)

The Impact of HIV Upon the PCI Results: A Systematic Review and Meta‐Analysis
di: Amr Ehab El‐Qushayri, et al.
Pubblicazione: (2024)

Cost‐effectiveness analysis of cell‐based versus egg‐based quadrivalent influenza vaccines in the pediatric population in Taiwan
di: Chia‐Yu Chi, et al.
Pubblicazione: (2024)

Fatal Hepatitis B Reactivation in Absence of Antibody to Hepatitis B Core Antigen in a Lymphoma Patient
di: Solenn Klutsch, et al.
Pubblicazione: (2025)

Hepatitis B Non‐Vaccination Rate and Associated Factors Among Healthcare Workers in Low‐ and Middle‐Income Countries: A Systematic Review and Meta‐Analysis
di: Alphonce Ignace Marealle, et al.
Pubblicazione: (2026)

Effect of Comorbidities on the Mortality of Patients With COVID‐19: A Systematic Review of Reviews and Meta‐Analyses
di: Karla Larissa Trassi Ganaza‐Domingues, et al.
Pubblicazione: (2025)

Clinical performance of Circulating HBV RNA and iTACT‐HBcrAg Assays in HBeAg‐negative and HBsAg‐cleared Chronic Hepatitis B Patients
di: Takanori Suzuki, et al.
Pubblicazione: (2024)

EBV and CMV Seroprevalence and Liver Injury Patterns Among Clinical Patients in Beijing: Differential Impact of Immunosuppression Status
di: Zhaoxiang Du, et al.
Pubblicazione: (2026)

Circulating Cell‐Free Mitochondrial DNA as a Prognostic Biomarker in Patients With HBV‐Related Acute‐on‐Chronic Liver Failure
di: Qiankun Hu, et al.
Pubblicazione: (2025)

Global, Regional, and National Burdens of Hepatitis E From 1990 to 2021 and Predicted 2030 Incidence: Results From the Global Burden of Disease Study 2021
di: Bai‐Yun Wu, et al.
Pubblicazione: (2025)

Hepatitis B Core‐Related Antigen Level Predicts Disease Progression in the Gray Zone Hepatitis B Patients
di: Takanori Suzuki, et al.
Pubblicazione: (2026)

Comparison of Azvudine and Nirmatrelvir‐Ritonavir in Hospitalised Patients With COVID‐19: A Systematic Review and Meta‐Analysis
di: Tahoora Mousavi, et al.
Pubblicazione: (2026)

Antiviral Therapy Reduces Dyslipidemia and Cardiovascular Risk in Chronic Hepatitis B: TDF as the Most Effective Agent
di: Hyuk Kim, et al.
Pubblicazione: (2025)